Featured News

On October 13, 2022 the Celiac Disease Foundation hosted the Ask-the-FDA Educational Webinar with representatives from the U.S. Food and Drug Administration and Coeliac UK.

The Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.

Please join the Celiac Disease Foundation for the upcoming Ask-the-FDA Educational Webinar.

Meet Celiac Disease Foundation Proud Sponsor empowerDX – an online shop for FDA-approved health testing that offers the at-home Celiac Disease Risk Gene Test.

Most of us have experienced the challenge of finding a public restroom, but for many, restroom access isn’t just a matter of convenience — it’s a serious medical issue.

The PROACTIVE Celiac Study is a phase 2 clinical trial testing the safety and effects of the investigational medication PRV-015.

If you have unexplained symptoms or have a family member with celiac disease, complete the Symptoms Assessment Tool to see if you have an increased risk for celiac disease – and receive a free product from CDF Proud Sponsor Schär. 

The need for action is clear. The failure to understand and treat celiac disease appropriately manifests in low rates of diagnosis, lack of research funding and alternative treatments, and limited understanding of the economic and social costs of this disease. 

Meet our runners for the 2022 TCS NYC Marathon!

Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.